iPSCs in Drug Discovery: Regulatory Shifts and Animal Models
FDA Modernization Act 2.0: Animal Testing No Longer Mandatory
.png)
Ncardia and Cellistic Appoint Gustavo Mahler to Lead Growth
Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO
Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer
Ncardia Secures $60+ Million to Expand iPSC Offerings
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
